This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 1.18a: National Management of End Stage Renal Disease, 2000
| Percent of patients with hematocrit 33 or greater, United States, 2000 |
| |
|
|
| Population group |
Percent |
Standard error |
| Age |
| 0-19 |
57.4 |
1.49 |
| 20-64 |
75.9 |
0.12 |
| 65 and over |
81.4 |
0.11 |
| Gender |
| Female |
77.3 |
0.12 |
| Male |
79.9 |
0.11 |
| Race |
| Asian |
81.8 |
0.42 |
| Black |
76.0 |
0.14 |
| Native American |
80.3 |
0.60 |
| White |
80.3 |
0.11 |
| Other race |
79.7 |
0.71 |
| End Stage Renal Disease cause |
| Diabetes |
79.3 |
0.13 |
| Hypertension |
79.4 |
0.16 |
| Glomerulonephritis |
78.2 |
0.24 |
| Other cause |
76.2 |
0.21 |
Source: The University of Michigan Kidney Epidemiology and Cost Center.
Return to Tables Appendix
Return to Contents